nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—ADRA2A—epilepsy syndrome	0.299	1	CbGaD
Tolazoline—Phenacemide—Felbamate—epilepsy syndrome	0.0824	0.141	CrCrCtD
Tolazoline—L-Phenylalanine—Felbamate—epilepsy syndrome	0.0608	0.104	CrCrCtD
Tolazoline—Mephentermine—Lacosamide—epilepsy syndrome	0.0608	0.104	CrCrCtD
Tolazoline—Phenelzine—Lacosamide—epilepsy syndrome	0.0584	0.0997	CrCrCtD
Tolazoline—Phentermine—Lacosamide—epilepsy syndrome	0.0561	0.0959	CrCrCtD
Tolazoline—Antazoline—Phenytoin—epilepsy syndrome	0.0481	0.0822	CrCrCtD
Tolazoline—Phenacemide—Lacosamide—epilepsy syndrome	0.0473	0.0808	CrCrCtD
Tolazoline—Dextroamphetamine—Lacosamide—epilepsy syndrome	0.0459	0.0784	CrCrCtD
Tolazoline—Amphetamine—Lacosamide—epilepsy syndrome	0.0459	0.0784	CrCrCtD
Tolazoline—Methamphetamine—Lacosamide—epilepsy syndrome	0.0446	0.0762	CrCrCtD
Tolazoline—L-Phenylalanine—Lacosamide—epilepsy syndrome	0.0349	0.0597	CrCrCtD
Tolazoline—Phenacemide—SCN1A—epilepsy syndrome	0.000934	0.28	CrCbGaD
Tolazoline—Phenelzine—ABAT—epilepsy syndrome	0.000565	0.169	CrCbGaD
Tolazoline—ADRA1A—hindbrain—epilepsy syndrome	0.000502	0.0729	CbGeAlD
Tolazoline—L-Phenylalanine—TH—epilepsy syndrome	0.000426	0.128	CrCbGaD
Tolazoline—Naphazoline—ADRA2A—epilepsy syndrome	0.000341	0.102	CrCbGaD
Tolazoline—HRH2—head—epilepsy syndrome	0.000325	0.0471	CbGeAlD
Tolazoline—HRH2—nervous system—epilepsy syndrome	0.000308	0.0447	CbGeAlD
Tolazoline—HRH2—central nervous system—epilepsy syndrome	0.000296	0.043	CbGeAlD
Tolazoline—ADRA1A—brainstem—epilepsy syndrome	0.000288	0.0418	CbGeAlD
Tolazoline—ADRA1A—forebrain—epilepsy syndrome	0.000278	0.0403	CbGeAlD
Tolazoline—ADRA1A—telencephalon—epilepsy syndrome	0.000256	0.0371	CbGeAlD
Tolazoline—ADRA2C—telencephalon—epilepsy syndrome	0.000244	0.0354	CbGeAlD
Tolazoline—HRH2—brain—epilepsy syndrome	0.000235	0.0341	CbGeAlD
Tolazoline—HRH1—forebrain—epilepsy syndrome	0.000215	0.0312	CbGeAlD
Tolazoline—ADRA2A—forebrain—epilepsy syndrome	0.000211	0.0307	CbGeAlD
Tolazoline—HRH1—telencephalon—epilepsy syndrome	0.000198	0.0287	CbGeAlD
Tolazoline—ADRA2A—telencephalon—epilepsy syndrome	0.000194	0.0282	CbGeAlD
Tolazoline—ADRA2C—medulla oblongata—epilepsy syndrome	0.000191	0.0278	CbGeAlD
Tolazoline—ADRA2C—midbrain—epilepsy syndrome	0.000175	0.0254	CbGeAlD
Tolazoline—ADRA2C—spinal cord—epilepsy syndrome	0.000171	0.0248	CbGeAlD
Tolazoline—ADRA1A—head—epilepsy syndrome	0.000159	0.0231	CbGeAlD
Tolazoline—ADRA2A—medulla oblongata—epilepsy syndrome	0.000153	0.0222	CbGeAlD
Tolazoline—ADRA2C—head—epilepsy syndrome	0.000152	0.022	CbGeAlD
Tolazoline—ADRA1A—nervous system—epilepsy syndrome	0.000151	0.0219	CbGeAlD
Tolazoline—Phentermine—SLC6A4—epilepsy syndrome	0.000147	0.044	CrCbGaD
Tolazoline—ADRA1A—central nervous system—epilepsy syndrome	0.000145	0.0211	CbGeAlD
Tolazoline—ADRA2C—nervous system—epilepsy syndrome	0.000144	0.0209	CbGeAlD
Tolazoline—ADRA1A—cerebellum—epilepsy syndrome	0.000142	0.0206	CbGeAlD
Tolazoline—ADRA2A—midbrain—epilepsy syndrome	0.00014	0.0203	CbGeAlD
Tolazoline—ADRA2C—central nervous system—epilepsy syndrome	0.000138	0.0201	CbGeAlD
Tolazoline—Methamphetamine—ADRA2A—epilepsy syndrome	0.000137	0.0411	CrCbGaD
Tolazoline—ADRA2A—spinal cord—epilepsy syndrome	0.000136	0.0198	CbGeAlD
Tolazoline—ADRA2C—cerebellum—epilepsy syndrome	0.000135	0.0196	CbGeAlD
Tolazoline—HRH1—head—epilepsy syndrome	0.000123	0.0179	CbGeAlD
Tolazoline—ADRA2A—head—epilepsy syndrome	0.000121	0.0176	CbGeAlD
Tolazoline—HRH1—nervous system—epilepsy syndrome	0.000117	0.017	CbGeAlD
Tolazoline—ADRA1A—brain—epilepsy syndrome	0.000115	0.0167	CbGeAlD
Tolazoline—ADRA2A—nervous system—epilepsy syndrome	0.000115	0.0167	CbGeAlD
Tolazoline—Phenelzine—CYP2C19—epilepsy syndrome	0.000113	0.034	CrCbGaD
Tolazoline—Amphetamine—SLC6A4—epilepsy syndrome	0.000113	0.0338	CrCbGaD
Tolazoline—HRH1—central nervous system—epilepsy syndrome	0.000112	0.0163	CbGeAlD
Tolazoline—ADRA2A—central nervous system—epilepsy syndrome	0.00011	0.016	CbGeAlD
Tolazoline—ADRA2C—brain—epilepsy syndrome	0.00011	0.016	CbGeAlD
Tolazoline—ADRA2A—cerebellum—epilepsy syndrome	0.000108	0.0157	CbGeAlD
Tolazoline—Methamphetamine—SLC6A4—epilepsy syndrome	0.000105	0.0313	CrCbGaD
Tolazoline—Phentermine—CYP2D6—epilepsy syndrome	0.000103	0.0309	CrCbGaD
Tolazoline—Benzyl alcohol—CYP2D6—epilepsy syndrome	9.94e-05	0.0298	CrCbGaD
Tolazoline—Dextroamphetamine—CYP2D6—epilepsy syndrome	9.83e-05	0.0295	CrCbGaD
Tolazoline—HRH1—brain—epilepsy syndrome	8.93e-05	0.013	CbGeAlD
Tolazoline—ADRA2A—brain—epilepsy syndrome	8.77e-05	0.0127	CbGeAlD
Tolazoline—Amphetamine—CYP2D6—epilepsy syndrome	7.93e-05	0.0238	CrCbGaD
Tolazoline—Methamphetamine—CYP2D6—epilepsy syndrome	7.34e-05	0.022	CrCbGaD
Tolazoline—ADRA2C—Signaling Pathways—HBEGF—epilepsy syndrome	6.81e-06	6.44e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	6.79e-06	6.43e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	6.76e-06	6.4e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	6.75e-06	6.39e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	6.75e-06	6.39e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT3—epilepsy syndrome	6.68e-06	6.33e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	6.66e-06	6.31e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—POMC—epilepsy syndrome	6.64e-06	6.29e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	6.63e-06	6.28e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—S100B—epilepsy syndrome	6.61e-06	6.26e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SOCS3—epilepsy syndrome	6.54e-06	6.19e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CDC42—epilepsy syndrome	6.53e-06	6.18e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ADAM10—epilepsy syndrome	6.53e-06	6.18e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	6.52e-06	6.18e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	6.52e-06	6.18e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	6.52e-06	6.17e-05	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	6.51e-06	6.17e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PTK2B—epilepsy syndrome	6.5e-06	6.16e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TSC1—epilepsy syndrome	6.5e-06	6.16e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CCL2—epilepsy syndrome	6.5e-06	6.15e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	6.49e-06	6.15e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	6.47e-06	6.12e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AGT—epilepsy syndrome	6.41e-06	6.07e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	6.4e-06	6.06e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	6.4e-06	6.06e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	6.4e-06	6.06e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	6.4e-06	6.06e-05	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	6.39e-06	6.05e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	6.38e-06	6.04e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	6.37e-06	6.03e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GPX1—epilepsy syndrome	6.36e-06	6.02e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	6.35e-06	6.01e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	6.33e-06	5.99e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	6.33e-06	5.99e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	6.33e-06	5.99e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AVP—epilepsy syndrome	6.32e-06	5.98e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—FGF2—epilepsy syndrome	6.31e-06	5.98e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	6.28e-06	5.95e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	6.28e-06	5.95e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	6.27e-06	5.94e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	6.26e-06	5.93e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	6.25e-06	5.91e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—S100B—epilepsy syndrome	6.17e-06	5.84e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	6.16e-06	5.84e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	6.13e-06	5.8e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SOCS3—epilepsy syndrome	6.11e-06	5.79e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CDC42—epilepsy syndrome	6.1e-06	5.77e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	6.06e-06	5.74e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—SRC—epilepsy syndrome	6.06e-06	5.74e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HES1—epilepsy syndrome	5.98e-06	5.66e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	5.95e-06	5.64e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	5.95e-06	5.63e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	5.95e-06	5.63e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	5.95e-06	5.63e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	5.94e-06	5.62e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	5.92e-06	5.61e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	5.92e-06	5.6e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	5.9e-06	5.59e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AVP—epilepsy syndrome	5.9e-06	5.59e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	5.9e-06	5.58e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—RELA—epilepsy syndrome	5.86e-06	5.55e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	5.84e-06	5.53e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	5.84e-06	5.53e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	5.84e-06	5.53e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	5.82e-06	5.51e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	5.81e-06	5.5e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—FYN—epilepsy syndrome	5.81e-06	5.5e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	5.8e-06	5.5e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—H2AFX—epilepsy syndrome	5.79e-06	5.48e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	5.79e-06	5.48e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	5.79e-06	5.48e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MEF2C—epilepsy syndrome	5.78e-06	5.47e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MTOR—epilepsy syndrome	5.75e-06	5.44e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CAT—epilepsy syndrome	5.71e-06	5.4e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	5.71e-06	5.4e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	5.7e-06	5.39e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	5.68e-06	5.38e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	5.59e-06	5.29e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HES1—epilepsy syndrome	5.58e-06	5.28e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AGT—epilepsy syndrome	5.57e-06	5.28e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	5.55e-06	5.26e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	5.53e-06	5.23e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NGF—epilepsy syndrome	5.52e-06	5.23e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—S100B—epilepsy syndrome	5.5e-06	5.21e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—APOE—epilepsy syndrome	5.46e-06	5.17e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	5.44e-06	5.15e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	5.43e-06	5.14e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—FYN—epilepsy syndrome	5.43e-06	5.14e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	5.43e-06	5.14e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—H2AFX—epilepsy syndrome	5.41e-06	5.12e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MEF2C—epilepsy syndrome	5.4e-06	5.11e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	5.4e-06	5.11e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	5.39e-06	5.11e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCR5—epilepsy syndrome	5.37e-06	5.09e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	5.34e-06	5.06e-05	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.34e-06	5.05e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	5.33e-06	5.05e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	5.3e-06	5.02e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CASP3—epilepsy syndrome	5.29e-06	5e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	5.28e-06	5e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AVP—epilepsy syndrome	5.26e-06	4.98e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	5.26e-06	4.98e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—YWHAZ—epilepsy syndrome	5.22e-06	4.94e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GPX1—epilepsy syndrome	5.16e-06	4.89e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	5.16e-06	4.89e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NGF—epilepsy syndrome	5.16e-06	4.88e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—JUN—epilepsy syndrome	5.13e-06	4.86e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCR5—epilepsy syndrome	5.02e-06	4.75e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	5.01e-06	4.75e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MMP9—epilepsy syndrome	5e-06	4.73e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	4.99e-06	4.73e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	4.99e-06	4.72e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HES1—epilepsy syndrome	4.97e-06	4.71e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	4.97e-06	4.7e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	4.96e-06	4.7e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	4.95e-06	4.69e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	4.91e-06	4.65e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	4.89e-06	4.63e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	4.88e-06	4.62e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—AKT1—epilepsy syndrome	4.85e-06	4.59e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FYN—epilepsy syndrome	4.84e-06	4.58e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	4.82e-06	4.56e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	4.81e-06	4.55e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	4.79e-06	4.54e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	4.79e-06	4.53e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	4.74e-06	4.49e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	4.73e-06	4.48e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	4.72e-06	4.47e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—POMC—epilepsy syndrome	4.69e-06	4.44e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	4.67e-06	4.42e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	4.66e-06	4.41e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.65e-06	4.4e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	4.64e-06	4.39e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	4.61e-06	4.36e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—SRC—epilepsy syndrome	4.61e-06	4.36e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NGF—epilepsy syndrome	4.6e-06	4.35e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	4.59e-06	4.35e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	4.57e-06	4.32e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	4.56e-06	4.32e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	4.53e-06	4.29e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AGT—epilepsy syndrome	4.53e-06	4.29e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	4.51e-06	4.27e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—VEGFA—epilepsy syndrome	4.49e-06	4.25e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	4.47e-06	4.23e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	4.47e-06	4.23e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—APOE—epilepsy syndrome	4.44e-06	4.2e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	4.41e-06	4.17e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	4.39e-06	4.16e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	4.39e-06	4.15e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	4.38e-06	4.15e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	4.38e-06	4.14e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	4.31e-06	4.08e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	4.29e-06	4.06e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	4.29e-06	4.06e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ALB—epilepsy syndrome	4.28e-06	4.05e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	4.24e-06	4.01e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	4.2e-06	3.98e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	4.19e-06	3.97e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	4.16e-06	3.94e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AGT—epilepsy syndrome	4.15e-06	3.93e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	4.11e-06	3.89e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	4.08e-06	3.86e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	4.08e-06	3.86e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	4.07e-06	3.86e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APOE—epilepsy syndrome	4.07e-06	3.85e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	3.99e-06	3.78e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	3.99e-06	3.78e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—KDR—epilepsy syndrome	3.98e-06	3.77e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	3.92e-06	3.71e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	3.91e-06	3.7e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	3.84e-06	3.63e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	3.84e-06	3.63e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	3.82e-06	3.62e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—POMC—epilepsy syndrome	3.81e-06	3.61e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	3.79e-06	3.59e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	3.78e-06	3.58e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	3.77e-06	3.57e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	3.76e-06	3.56e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	3.75e-06	3.55e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	3.74e-06	3.54e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	3.71e-06	3.52e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	3.71e-06	3.51e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	3.63e-06	3.44e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	3.5e-06	3.31e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—POMC—epilepsy syndrome	3.49e-06	3.31e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	3.48e-06	3.3e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ALB—epilepsy syndrome	3.47e-06	3.29e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	3.47e-06	3.28e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	3.45e-06	3.26e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	3.43e-06	3.25e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	3.42e-06	3.24e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	3.38e-06	3.2e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	3.35e-06	3.18e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	3.22e-06	3.05e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	3.19e-06	3.02e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	3.16e-06	2.99e-05	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.14e-06	2.97e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	3.12e-06	2.95e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	3.11e-06	2.94e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	3.09e-06	2.93e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	3.04e-06	2.88e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	3.03e-06	2.87e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	3.02e-06	2.86e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	2.94e-06	2.78e-05	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	2.93e-06	2.78e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	2.9e-06	2.75e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RELA—epilepsy syndrome	2.87e-06	2.72e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—AKT1—epilepsy syndrome	2.86e-06	2.71e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	2.85e-06	2.7e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	2.82e-06	2.67e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	2.82e-06	2.67e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	2.81e-06	2.66e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	2.81e-06	2.66e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	2.76e-06	2.61e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	2.74e-06	2.6e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	2.71e-06	2.56e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.66e-06	2.52e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	2.64e-06	2.5e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	2.62e-06	2.48e-05	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.61e-06	2.47e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	2.59e-06	2.45e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	2.56e-06	2.43e-05	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.56e-06	2.43e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	2.54e-06	2.4e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	2.53e-06	2.4e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.51e-06	2.38e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	2.47e-06	2.33e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.46e-06	2.33e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.44e-06	2.31e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	2.4e-06	2.27e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.38e-06	2.25e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	2.37e-06	2.25e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	2.36e-06	2.23e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.33e-06	2.2e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	2.29e-06	2.17e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SRC—epilepsy syndrome	2.25e-06	2.13e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	2.23e-06	2.11e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	2.21e-06	2.09e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	2.2e-06	2.08e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.16e-06	2.05e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.15e-06	2.04e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	2.06e-06	1.95e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2e-06	1.9e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AKT1—epilepsy syndrome	1.88e-06	1.78e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	1.68e-06	1.59e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	1.57e-06	1.49e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AKT1—epilepsy syndrome	1.53e-06	1.45e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.4e-06	1.33e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.37e-06	1.3e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.28e-06	1.21e-05	CbGpPWpGaD
